Welcome to the Kantar Health Events Page RSS Feed Events

Connect with us at a healthcare industry or pharma event

33rd ICPE Annual Conference

  • Dates: 26 – 30 Aug, 2017
  • Location: Montreal, Canada

PIONEERS IN PHARMACOEPIDEMIOLOGICAL RESEARCH

kh_icpe2017_landing_page_final visual

Kantar Health and ZEG Berlin, a Kantar Health company, are proud to sponsor the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) taking place in Montreal, Canada on August 26-30, 2017.

Come visit us in the exhibit hall to engage with our experts or see us at our podium and research poster presentations.

Presentation

Monday Aug 28, 2017, 5:45 - 6:00 PM

Cardiovascular Safety in Users of Different Combined Oral Contraceptives - Final Results from the INAS-SCORE Study
Session Title:  (Cardio) Vascular Safety Outcomes
Publication Number: 74
Room: 524AB

Posters

Tuesday Aug 29, 2017 8:00 AM - 6:00 PM

Unintended Pregnancies in Users of Different Combined Oral Contraceptives - Final Results from the INAS-SCORE Study
Poster Session B          : Intended Effects of Medications - Real World  Comparative Effectiveness
Publication Number      : 606
Room                           : 220BC

The Influence of Women’s Educational Level on Unintended Pregnancy Rates Amongst Users of Combined Oral Contraceptives
Poster Session B          : Intended Effects of Medications - Real World Comparative Effectiveness
Pulication Number       : 607
Room                           : 220BC

Safety and Efficacy of Intrauterine Devices: Baseline Characteristics of 26,053 Study Participants from the EURAS-LCS12 Study
Poster Session B          : Medical Devices
Publication Number      : 621
Room                           : 220BC

Wednesday Aug 30, 2017 8:00 AM - 1:45 PM

Comparison of Real World Patient Data Sources: A Global Case Study
Poster Session C          :  Data Sources for Pharmacoepidemiology
Publication Number      :  932
Room                           :  220BC

Hormonal Treatment of Endometriosis: Comparative Data from the VIPOS Study
Poster Session C          :  Drug Utilization - Various Conditions
Publication Number      :  967
Room                           :  220BC

Drug Utilization Study on the Prescribing Indications for CPA/EE in 5 European Countries
Poster Session C          : Prescribing and Dispensing
Publication Number      : 988
Room                           :  220BC

 cta2

 

Share

Latest News

  • Kantar Health and Nokia Partner on Innovative Diabetes Database

    May 22, 2017

    Read More

  • Roche Reaches Top Image Values in the Areas of Lung Cancer, Breast/Ovarian Cancer

    Feb 24, 2017

    Read More

  • Novartis Has Top Image Among German Cardiologists, While Boehringer Ingelheim, Novartis Lead Among Pulmonologists

    Feb 15, 2017

    Read More